Sumitomo Banking to Exit Kotak Mahindra Bank with $700M Stake Sale; Blue Jet Healthcare Promoter Offers ₹800 Crore Stake

1 min read     Updated on 09 Sept 2025, 08:01 PM
scanx
Reviewed by
Radhika SahaniScanX News Team
whatsapptwittershare
Overview

Sumitomo Banking Corporation plans to sell its entire 1.65% stake in Kotak Mahindra Bank through a block deal worth up to $700 million, with 3.28 crore shares at a floor price of ₹1,880.00 per share. Separately, Blue Jet Healthcare's promoter, Akshay Bansarilal Arora, announced an offer for sale of up to 6.83% stake, valued at ₹800 crore, with an offer price of ₹675.00 per share.

18973924

*this image is generated using AI for illustrative purposes only.

Sumitomo Banking Corporation, a Japanese financial institution, is set to make a significant move in the Indian banking sector by selling its entire 1.65% stake in Kotak Mahindra Bank. Concurrently, Blue Jet Healthcare's promoter has announced a substantial stake sale through an offer for sale (OFS).

Sumitomo's Exit from Kotak Mahindra Bank

Sumitomo Banking Corporation is planning to divest its entire 1.65% stake in Kotak Mahindra Bank through a block deal valued at up to $700 million. The key details of this transaction are:

  • Number of shares to be sold: Up to 3.28 crore
  • Floor price: ₹1,880.00 per share
  • Discount: 4.1% to Kotak Bank's closing price

This move marks the end of Sumitomo's investment journey with Kotak Mahindra Bank, which began in 2010 when it acquired a 4.5% stake for ₹1,366.00 crore at ₹833.00 per share.

Kotak Mahindra Bank's Stock Performance

Kotak Mahindra Bank's stock has shown positive momentum this year:

  • Year-to-date increase: 9.6%
  • Recent high: ₹2,268.80 (reached in April)

Blue Jet Healthcare Promoter's Stake Sale

In a separate development, Akshay Bansarilal Arora, promoter of Blue Jet Healthcare, has announced an offer for sale (OFS) of up to 6.83% stake. The details of this offer are:

  • Total offer value: Up to ₹800.00 crore
  • Base offer size: ₹400.00 crore
  • Oversubscription option: Additional ₹400.00 crore
  • Offer price: ₹675.00 per share (7.6% discount to the closing price)

The OFS timeline is as follows:

  • Non-retail investors: Opens on September 10
  • Retail investors: Opens on September 11

Blue Jet Healthcare's Market Performance

Blue Jet Healthcare, which listed in 2023, has shown remarkable growth:

  • Stock appreciation since listing: Over 87%

These stake sales by Sumitomo Banking Corporation and Blue Jet Healthcare's promoter represent significant movements in their respective sectors, potentially impacting market dynamics and investor sentiment in the coming days.

like18
dislike
Explore Other Articles